|
|
|
|
|
Legal status
Application deemed to be withdrawn
| (51) | INT.CL.: (2006.01) |
A61K 38/00 A61K 38/22 A61P 25/00 C07K 14/00 C07K 14/435 C07K 14/82 C07K 19/00 C12N 15/00 C12N 15/16 C12P 21/02 C12Q 1/68 |
| (11) | Number of the document | |
| (13) | Kind of document | A |
| (21) | Application number | IP1529 |
| (22) | Date of filing the application | 1993-12-06 |
| (41) | Date of publication of the application | 1995-07-25 |
| (45) | Date of publication of patent |
| (30) | Number | Date | Country code |
| 564929 | 1990-08-08 | US | |
| PCT/US91/05610 | 1991-08-07 | WO | |
| 5011316 | 1992-01-31 | SU |
| (71) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill Road, Tarrytown, NY 10591-6707,
US
|
| (72) |
Stephen P. SQUINTO, US
Eric M. SHOOTER, US Ulrich SUTER, US Nancy IP, US Mark E. FURTH, US Ronald M. LINDSAY, US |
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | CHIMERIC NEUROTROPHIC FACTOR, PHARMACEUTICAL COMPOSITION, NUCLEIC ACIDS |